Isarna Therapeutics develops cytokine human transforming growth inhibitors that stimulate the human immune system to fight cancer.
Business Model:
Revenue: $15.7M
Employees: 51-200
Address: Leopoldstrasse 254-256
City: Munich
State: other
Zip: 80807
Country: DE
Isarna Therapeutics develops cytokine human transforming growth inhibitors that stimulate the human immune system to fight cancer.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2004 | Venture Round | $0 |
Global Asset Fund Global Chance Fund Global Asset Fund Global Chance Fund |
3/2010 | Venture Round | $0 |
Global Asset Fund MIG Global Asset Fund MIG |
7/2011 | Venture Round | $0 |
Global Asset Fund MIG Global Asset Fund MIG |
11/2007 | Venture Round | 1 | $39.6M |
MIG Capital MIG Capital |
4/2014 | Venture Round | $0 |
Global Asset Fund MIG Global Asset Fund MIG |
12/2005 | Private Equity Round | $0 |
Global Asset Capital Global Chance Fund MIG S-Refit Global Asset Capital Global Chance Fund MIG S-Refit |
1/2014 | Venture Round | 2 | $17.8M |
AT Impf MIG AT Impf MIG |
4/2014 | Equity | 2 | $7.6M |
MIG Fonds Global Asset Funds Global Asset Fund MIG |
7/2011 | Venture Round | 2 | $11.5M |
Global Asset Fund MIG Global Asset Fund MIG |
3/2010 | Venture Round | 2 | $17.8M |
Global Asset Fund MIG Global Asset Fund MIG |
11/2007 | Venture Round | 1 | $39.6M |
MIG MIG |
12/2005 | Private Equity Round | 4 | $18M |
Global Asset Capital Global Asset Capital |
4/2004 | Venture Round | 2 | $12M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|